Chief Executive Officer, Co - founder

MGI Tech's T7+ Sequencer Promises to Churn out 35K Human Genomes per Year

New Products Posted to GenomeWeb: Illumina, Oxford Nanopore, Arima Genomics

European stocks mixed ahead of eurozone CPI

Europe mixed as gold climbs amid US uncertainty

Market Segment Manager - Biopharma

Oxford Nanopore Technologies is a company focused on enabling the analysis of various biological molecules through its innovative nanopore-based sensing technology. They are seeking a Market Segment Manager for Biopharma to drive the adoption of their sequencing technology across the biopharmaceutical value chain, leading marketing strategy and commercial initiatives in critical application areas.

Sign up with Google

Sign in with Google